tiprankstipranks
Trending News
More News >

Samuel Riccitelli Insider Profile

4 Followers
Samuel Riccitelli, President & CEO, Director at Viridian Therapeutics, holds 571.37K shares in Viridian Therapeutics (Ticker: VRDN), holds ― shares in Precipio (Ticker: PRPO), holds 12.02K shares in OrthoPediatrics (Ticker: KIDS).
tipranks
Samuel Riccitelli

Samuel Riccitelli
Viridian Therapeutics (VRDN)
President & CEO, Director

Not Ranked
Samuel Riccitelli has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
96.76%
3.24%
0.00%
0.00%
A breakdown of Samuel Riccitelli's holdings

Insider Roles

Viridian Therapeutics
(VRDN)
President & CEO, Director
OrthoPediatrics
(KIDS)
Director
Precipio
(PRPO)
Director
Biocept
(BIOCQ)
Interim President and CEO, Director
Roles that Samuel Riccitelli holds in companies

Most Profitable Insider Trade

Stock:
Viridian Therapeutics
(VRDN)
Rating:Informative Buy
Date:Nov 23, 2015 - Nov 23, 2016
Return:-29.00%
The most profitable trade made by Samuel Riccitelli

Samuel Riccitelli's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Viridian Therapeutics
Nov 02, 2016
President & CEO, Director
Uninformative Buy
34.86K
$9.11M
Precipio
Director
OrthoPediatrics
May 30, 2024
Director
Uninformative Buy
$304.76K
Biocept
Interim President and CEO, Director
List of latest transactions for each holding click on a transaction to see Samuel Riccitelli's performance on stock

Samuel Riccitelli insider profile FAQ

What is the percentage of profitable transactions made by Samuel Riccitelli?
The percentage of profitable transactions made by Samuel Riccitelli is ―.
    What is the average return per transaction made by Samuel Riccitelli?
    The average return per transaction made by Samuel Riccitelli is ―.
      What stocks does Samuel Riccitelli hold?
      Samuel Riccitelli holds: VRDN, PRPO, KIDS, BIOCQ stocks.
        What was Samuel Riccitelli’s latest transaction?
        Samuel Riccitelli latest transaction was an Uninformative Buy of $34.86K.
          What was Samuel Riccitelli's most profitable transaction?
          Samuel Riccitelli’s most profitable transaction was an Informative Buy of VRDN stock on November 23, 2015. The return on the trade was -29.00%.
            What is Samuel Riccitelli's role in Viridian Therapeutics?
            Samuel Riccitelli's role in Viridian Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.